TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT06108739

ATG Plus Low-dose PT-Cy for GVHD Prevention

Cause of deathFutility Automatic label, confidence 0.9, unverified. How labels are made.
“DSMB recommended halting the study owing to futility after the first interim analysis in August 2024.”

The sponsor’s own words in the registry.

Life of this trial

2023202420252026Registered2023-10-22Started2023-11-01Stopped2024-12-31

Vital statistics

Status
Terminated
Phase
Phase 3
Sponsor
Peking University People's Hospital
Sponsor type
University, hospital or other
Conditions
Hematologic Malignancy
Interventions
Cyclophosphamid; ATG
Participants
66
Sites
1
Countries
China

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.